LONGBOARD PHARMACEUTICALS IN's ticker is LBPH and the CUSIP is 54300N103. A total of 52 filers reported holding LONGBOARD PHARMACEUTICALS IN in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,748,686 | -37.7% | 2,113,073 | -17.8% | 0.00% | -50.0% |
| Q2 2023 | $18,857,612 | -17.3% | 2,569,157 | -55.7% | 0.00% | +100.0% |
| Q1 2023 | $22,797,082 | +552.9% | 5,800,784 | +425.0% | 0.00% | – |
| Q4 2022 | $3,491,497 | +5.3% | 1,104,904 | +23.9% | 0.00% | – |
| Q3 2022 | $3,316,000 | +20.4% | 891,500 | -0.0% | 0.00% | – |
| Q2 2022 | $2,755,000 | -49.4% | 891,506 | -15.0% | 0.00% | – |
| Q1 2022 | $5,445,000 | -25.8% | 1,048,962 | -30.8% | 0.00% | -100.0% |
| Q4 2021 | $7,336,000 | -51.2% | 1,515,583 | -10.3% | 0.00% | 0.0% |
| Q3 2021 | $15,048,000 | -19.0% | 1,688,821 | -17.1% | 0.00% | 0.0% |
| Q2 2021 | $18,585,000 | -42.9% | 2,037,831 | +2.2% | 0.00% | -66.7% |
| Q1 2021 | $32,528,000 | – | 1,993,136 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 2,353,141 | $13,083,464 | 0.76% |
| Integral Health Asset Management, LLC | 760,000 | $4,225,600 | 0.58% |
| Prosight Management, LP | 321,154 | $1,785,616 | 0.57% |
| Parkman Healthcare Partners LLC | 355,957 | $1,979,121 | 0.36% |
| Ikarian Capital, LLC | 514,101 | $2,858,401 | 0.34% |
| FARALLON CAPITAL MANAGEMENT LLC | 1,560,500 | $8,676,380 | 0.04% |
| Polar Capital Holdings Plc | 1,000,000 | $5,560,000 | 0.04% |
| UBS OCONNOR LLC | 262,265 | $1,458,193 | 0.04% |
| BOOTHBAY FUND MANAGEMENT, LLC | 112,614 | $626,134 | 0.02% |
| Point72 Asset Management, L.P. | 825,000 | $4,587,000 | 0.01% |